echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cell Death Differ: Bedaquiline targets ATP5F1C to prevent cancer cell metastasis

    Cell Death Differ: Bedaquiline targets ATP5F1C to prevent cancer cell metastasis

    • Last Update: 2021-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ATP is the universal biological energy "currency" for all living cells and tissues.


    ATP is the universal biological energy "currency" for all living cells and tissues.


    Conversely, mitochondrial dysfunction can deplete ATP, leading to autophagy, apoptosis (programmed cell death) or necrosis.


    ATP depletion therapy may be used as a feasible strategy to target cancer cells.


    In this study, the researchers found that the high ATP production of mitochondrial ATP synthase is a new therapeutic target for anti-cancer therapy (especially the prevention of tumor development).


    Researchers have found that the high ATP production of mitochondrial ATP synthase is a new therapeutic target for anti-cancer therapy (especially to prevent tumor development).



    Increased expression of ATP5F1C protein in lymph nodes

    Increased expression of ATP5F1C protein in lymph nodes

    Importantly, the researchers found that the transfer ability of MDA-MB-231 cells with high ATP levels increased nearly five times.


    The components of mitochondrial complex I–V (including ATP5F1C) and markers related to circulating tumor cells (CTC) and metastasis (such as EpCAM and VCAM1) are overexpressed in cells with high ATP levels.



    Cells with high ATP levels exhibit multidrug resistance

    Cells with high ATP levels exhibit multidrug resistance

    In summary, the results of this study show that mitochondrial ATP depletion is a new type of treatment strategy to prevent cancer metastasis and avoid treatment failure.


    Mitochondrial ATP depletion is a new type of treatment strategy to prevent cancer metastasis and avoid treatment failure.



    org/10.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.